Ravenel Boykin Curry IV
Eagle Capital Management
Eagle Capital Management Merck & Company Inc stake
total: 177
Eagle Capital Management MRK trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2021 Q3
According to 2026 Q2 report, Eagle Capital Management doesn't hold any Merck & Company Inc (MRK) shares. To date, the estimated cost basis is nearly $77.75 for "buy" trades and estimated average "sell" price is $77.75. Eagle Capital Management first purchased MRK in 2021 Q2, initially acquiring 5,595 shares. Since the initial investment in Merck & Company Inc (MRK), Eagle Capital Management has made 1 more transaction.
When did Eagle Capital Management sell Merck & Company Inc (MRK)?
Eagle Capital Management sold off the entire Merck & Company Inc (MRK) position in 2021 Q3.
When did Eagle Capital Management buy Merck & Company Inc (MRK)?
Eagle Capital Management first invested in Merck & Company Inc (MRK) in 2021 Q2 at the reported quarter-end price of $77.75 per share.
What's the cost basis of Eagle Capital Management's MRK stake?
The estimated cost basis for Merck & Company Inc (MRK) stake is around $77.75 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $77.75
- Weighted AVG sell price:
- $77.75
Eagle Capital Management's historical trades in Merck & Company Inc
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q3
|
0.00%
|
0
|
$77.75
|
|
-100% (-5,595)
|
-0%
|
|
2021 Q2
|
0.00%
|
5,595
|
$77.75
|
$435,000
|
new
|
+0%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.